Serum ferritin and Hodgkin's disease

Area of Science:

• Hematology
• Oncology
• Biochemistry

Background:

• Hodgkin's disease is a cancer of the lymphatic system.
• Iron metabolism is often dysregulated in malignant conditions.
• Understanding iron distribution is crucial for managing cancer patients.

Purpose of the Study:

• To investigate iron status and distribution in patients with Hodgkin's disease before treatment.
• To correlate iron parameters with the stage and severity of Hodgkin's disease.

Main Methods:

• Measured haemoglobin, serum iron, transferrin saturation, serum ferritin, ESR, splenic weight, and tissue non-haem iron.
• Analyzed 35 patients with Hodgkin's disease undergoing staging laparotomy.
• Correlated iron parameters with disease stage.

Main Results:

• Decreased haemoglobin, serum iron, and transferrin saturation with increasing disease stage.
• Increased serum ferritin, erythrocyte sedimentation rate (ESR), splenic weight, and tissue non-haem iron.
• Evidence of internal iron redistribution from haemoglobin to storage, particularly in the liver.
• Serum ferritin levels were disproportionately high compared to body iron stores, especially in advanced stages (4B) and with liver involvement.

Conclusions:

• Serum ferritin is elevated in Hodgkin's disease due to increased iron stores, its role as an acute-phase reactant, and potential hepatic damage.
• Iron redistribution occurs, favoring storage over incorporation into haemoglobin as the disease progresses.
• Elevated serum ferritin in Hodgkin's disease is multifactorial and indicates disease severity.